StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.87+0.15 (+4.03%)

Close on Nov 13, 2026Market cap $143.89MP/E –Yield –

Armata Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Armata Pharmaceuticals's cash was $18.32M at Sep 30, 2026. For fiscal 2025 it was $8.69M, down 41.2% from the year before. Over ten years it grew -0.8% a year on average. The highest annual figure on record is $20.81M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.69M-41.2%
FY2024Dec 31, 2024$14.77M-23.2%
FY2023Dec 31, 2023$19.24M-7.5%
FY2022Dec 31, 2022$20.81M+81.2%
FY2021Dec 31, 2021$11.49M+5.9%
FY2020Dec 31, 2020$10.85M+61.1%
FY2019Dec 31, 2019$6.73M-35.6%
FY2018Dec 31, 2018$10.46M-14.8%
FY2017Dec 31, 2017$12.28M+139.2%
FY2016Dec 31, 2016$5.13M-45.2%
FY2015Dec 31, 2015$9.37M+42.4%
FY2014Dec 31, 2014$6.58M-67.7%
FY2013Dec 31, 2013$20.36M+2261.4%
FY2012Dec 31, 2012$862.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$18.32M+24.1%
Q2 FY2026Jun 30, 2026$23.95M+453.4%
Q1 FY2026Mar 31, 2026$4.75M-59.3%
Q4 FY2025Dec 31, 2025$8.69M-41.2%
Q3 FY2025Sep 30, 2025$14.76M-13.9%
Q2 FY2025Jun 30, 2025$4.33M-83.6%
Q1 FY2025Mar 31, 2025$11.69M-69.1%
Q4 FY2024Dec 31, 2024$14.77M-23.2%
Q3 FY2024Sep 30, 2024$17.14M-28.5%
Q2 FY2024Jun 30, 2024$26.41M+112.0%
Q1 FY2024Mar 31, 2024$37.86M+50.8%
Q4 FY2023Dec 31, 2023$19.24M-7.5%
Q3 FY2023Sep 30, 2023$23.96M-5.6%
Q2 FY2023Jun 30, 2023$12.46M-66.3%
Q1 FY2023Mar 31, 2023$25.11M-45.9%
Q4 FY2022Dec 31, 2022$20.81M+81.2%
Q3 FY2022Sep 30, 2022$25.38M+110.2%
Q2 FY2022Jun 30, 2022$36.98M+110.9%
Q1 FY2022Mar 31, 2022$46.41M+106.7%
Q4 FY2021Dec 31, 2021$11.49M+5.9%
Q3 FY2021Sep 30, 2021$12.08M-24.0%
Q2 FY2021Jun 30, 2021$17.54M-11.4%
Q1 FY2021Mar 31, 2021$22.46M-7.2%
Q4 FY2020Dec 31, 2020$10.85M+61.1%
Q3 FY2020Sep 30, 2020$15.89M+82.8%
Q2 FY2020Jun 30, 2020$19.79M+50.0%
Q1 FY2020Mar 31, 2020$24.21M+292.9%
Q4 FY2019Dec 31, 2019$6.73M-35.6%
Q3 FY2019Sep 30, 2019$8.69M-35.1%
Q2 FY2019Jun 30, 2019$13.19M-14.5%
Q1 FY2019Mar 31, 2019$6.16M-24.9%
Q4 FY2018Dec 31, 2018$10.46M-14.8%
Q3 FY2018Sep 30, 2018$13.39M+73.4%
Q2 FY2018Jun 30, 2018$15.42M+72.1%
Q1 FY2018Mar 31, 2018$8.21M+272.7%
Q4 FY2017Dec 31, 2017$12.28M+139.2%
Q3 FY2017Sep 30, 2017$7.73M–
Q2 FY2017Jun 30, 2017$8.96M–
Q1 FY2017Mar 31, 2017$2.20M–
Q4 FY2016Dec 31, 2016$5.13M–

More Armata Pharmaceuticals figures

See a number that looks wrong?